CareDx ROA 2013-2025 | CDNA
Current and historical return on assets (ROA) values for CareDx (CDNA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| CareDx ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.07B | $0.43B | 15.29% |
| 2025-06-30 | $0.06B | $0.44B | 12.20% |
| 2025-03-31 | $0.06B | $0.49B | 12.88% |
| 2024-12-31 | $0.05B | $0.49B | 11.02% |
| 2024-09-30 | $-0.15B | $0.48B | -33.06% |
| 2024-06-30 | $-0.17B | $0.47B | -35.19% |
| 2024-03-31 | $-0.19B | $0.45B | -38.45% |
| 2023-12-31 | $-0.19B | $0.47B | -37.79% |
| 2023-09-30 | $-0.09B | $0.50B | -17.25% |
| 2023-06-30 | $-0.08B | $0.52B | -15.77% |
| 2023-03-31 | $-0.08B | $0.53B | -15.02% |
| 2022-12-31 | $-0.08B | $0.54B | -14.15% |
| 2022-09-30 | $-0.08B | $0.55B | -13.64% |
| 2022-06-30 | $-0.07B | $0.54B | -12.62% |
| 2022-03-31 | $-0.05B | $0.55B | -8.95% |
| 2021-12-31 | $-0.03B | $0.57B | -5.57% |
| 2021-09-30 | $-0.02B | $0.56B | -3.74% |
| 2021-06-30 | $-0.01B | $0.56B | -2.20% |
| 2021-03-31 | $-0.02B | $0.54B | -3.73% |
| 2020-12-31 | $-0.02B | $0.37B | -6.53% |
| 2020-09-30 | $-0.02B | $0.35B | -8.33% |
| 2020-06-30 | $-0.02B | $0.35B | -10.01% |
| 2020-03-31 | $-0.02B | $0.16B | -14.07% |
| 2019-12-31 | $-0.02B | $0.15B | -16.20% |
| 2019-09-30 | $-0.02B | $0.15B | -16.09% |
| 2019-06-30 | $-0.04B | $0.14B | -32.45% |
| 2019-03-31 | $-0.05B | $0.13B | -42.79% |
| 2018-12-31 | $-0.05B | $0.13B | -49.34% |
| 2018-09-30 | $-0.08B | $0.09B | -89.82% |
| 2018-06-30 | $-0.07B | $0.08B | -86.79% |
| 2018-03-31 | $-0.06B | $0.08B | -74.68% |
| 2017-12-31 | $-0.06B | $0.08B | -70.66% |
| 2017-09-30 | $-0.04B | $0.08B | -50.32% |
| 2017-06-30 | $-0.03B | $0.08B | -34.42% |
| 2017-03-31 | $-0.04B | $0.08B | -39.00% |
| 2016-12-31 | $-0.04B | $0.08B | -47.56% |
| 2016-09-30 | $-0.03B | $0.10B | -37.79% |
| 2016-06-30 | $-0.03B | $0.10B | -42.42% |
| 2016-03-31 | $-0.02B | $0.05B | -37.33% |
| 2015-12-31 | $-0.01B | $0.06B | -21.76% |
| 2015-09-30 | $-0.01B | $0.06B | -13.11% |
| 2015-06-30 | $0.00B | $0.06B | -6.45% |
| 2015-03-31 | $0.00B | $0.06B | 0.00% |
| 2014-12-31 | $0.00B | $0.06B | 2.37% |
| 2014-09-30 | $0.00B | $0.06B | 0.00% |
| 2014-06-30 | $0.00B | $0.03B | -14.55% |
| 2014-03-31 | $0.00B | $0.01B | -76.19% |
| 2013-12-31 | $0.00B | $0.01B | -160.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.850B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.894B | 27.52 |
| HCA Healthcare (HCA) | United States | $107.981B | 17.88 |
| CVS Health (CVS) | United States | $99.714B | 11.47 |
| Elevance Health (ELV) | United States | $70.690B | 10.37 |
| Cencora (COR) | United States | $68.633B | 22.14 |
| Natera (NTRA) | United States | $27.439B | 0.00 |
| DiDi Global (DIDIY) | China | $24.144B | 19.73 |
| Labcorp Holdings (LH) | United States | $20.782B | 15.85 |
| Medpace Holdings (MEDP) | United States | $16.867B | 41.88 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| ICON (ICLR) | Ireland | $13.220B | 13.12 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.984B | 0.00 |
| Viatris (VTRS) | United States | $12.411B | 4.46 |
| CochLear (CHEOY) | Australia | $12.126B | 0.00 |
| Solventum (SOLV) | United States | $11.737B | 12.11 |
| Revvity (RVTY) | United States | $10.495B | 19.33 |
| Charles River Laboratories (CRL) | United States | $8.253B | 15.90 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.215B | 0.00 |
| HealthEquity (HQY) | United States | $8.132B | 32.55 |
| Avantor (AVTR) | United States | $7.895B | 12.06 |
| Sonic Healthcare (SKHHY) | Australia | $6.712B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.894B | 35.14 |
| Bausch + Lomb (BLCO) | Canada | $5.571B | 36.58 |
| Sotera Health (SHC) | United States | $4.492B | 21.66 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 22.50 |
| GeneDx Holdings (WGS) | United States | $3.932B | 69.48 |
| Alignment Healthcare (ALHC) | United States | $3.414B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.815B | 35.42 |
| Concentras Parent (CON) | United States | $2.453B | 15.56 |
| Premier (PINC) | United States | $2.324B | 22.52 |
| Ardent Health (ARDT) | United States | $2.099B | 8.10 |
| PACS (PACS) | United States | $1.957B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.863B | 11.12 |
| Establishment Labs Holdings (ESTA) | $1.753B | 0.00 | |
| Organon (OGN) | United States | $1.659B | 1.81 |
| Progyny (PGNY) | United States | $1.623B | 34.33 |
| Teladoc Health (TDOC) | United States | $1.430B | 0.00 |
| Omada Health (OMDA) | $1.342B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.157B | 18.50 |
| Embecta (EMBC) | United States | $0.811B | 4.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.791B | 9.78 |
| Nutex Health (NUTX) | United States | $0.730B | 11.05 |
| Pomdoctor - (POM) | China | $0.614B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.556B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.541B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.527B | 0.00 |
| CryoPort (CYRX) | United States | $0.427B | 0.00 |
| So-Young (SY) | China | $0.423B | 0.00 |
| Enhabit (EHAB) | United States | $0.416B | 18.66 |
| Auna S.A (AUNA) | Luxembourg | $0.402B | 6.03 |
| Charming Medical (MCTA) | $0.383B | 0.00 | |
| Oncology Institute (TOI) | United States | $0.382B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.377B | 0.00 |
| KindlyMD (NAKA) | United States | $0.355B | 0.00 |
| SBC Medicals (SBC) | United States | $0.330B | 7.23 |
| Agilon Health (AGL) | United States | $0.312B | 0.00 |
| LifeMD (LFMD) | United States | $0.267B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.230B | 0.00 |
| Beauty Health (SKIN) | United States | $0.186B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.146B | 24.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.133B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.116B | 0.00 |
| DocGo (DCGO) | United States | $0.106B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.027B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.97 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |